The Effects of Probiotic Bacillus Subtilis on the Cytotoxicity of Clostridium Perfringens Type a in Caco-2 Cell Culture

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2017 Jul 6

PMID 28676033

Citations 14

Authors

Maryam Poormontaseri

Saeid Hosseinzadeh

Seyed Shahram Shekarforoush

Tahereh Kalantari

Affiliations

Soon will be listed here.

Abstract

Background: Some Bacillus strains have recently been identified for potential use as probiotics and food additives. The present study evaluated the antimicrobial effects of Bacillus subtilis ATCC 6633 and its metabolite on the enterotoxin and vegetative cells, spore and germinated spore of Clostridium perfringens type A in Caco-2 cells.

Results: We used flow cytometry and MTT assays to evaluate the cytotoxicity effect of treatments. According to the results, the most cell survival was found in the 4% crude antimicrobial substance (CAS) with the vegetative form of C. perfringens among co-cultured groups. Furthermore, the apoptosis and necrosis in co-cultured groups were significantly decreased (P < 0.05).

Conclusion: The present results suggested the crucial role of the current probiotic in the control of various forms of C. perfringens type A which was investigated for the first time. Also, the majority of treatments showed higher cell viability in flow cytometry compared to the MTT assay.

Citing Articles

Investigating the production and synergistic antibacterial activity of bacteriocin-like substance from SA-14 (TISTR 2453) for enhanced wound healing.

Madoromae H, Atipairin A, Tayeh M, Lertcanawanichakul M Heliyon. 2025; 11(4):e42510.

PMID: 40028579 PMC: 11869030. DOI: 10.1016/j.heliyon.2025.e42510.

Anti-inflammatory, antioxidant effects, and antimicrobial effect of P223.

Jung H, Lee H, Kim K, Lee N, Paik H Food Sci Biotechnol. 2024; 33(9):2179-2187.

PMID: 39130667 PMC: 11315835. DOI: 10.1007/s10068-023-01445-4.

506 Protects the Intestinal Barrier from the Damaging Effects of Enteric Pathogens and Deoxynivalenol.

Boll E, Winther K, Knudsen T, Copani G, Cappellozza B Animals (Basel). 2024; 14(2).

PMID: 38254438 PMC: 10812616. DOI: 10.3390/ani14020269.

Expression of α- and ε-toxin genes in type D vaccine strain in contact with the Caco-2 cell line.

Forouzan A, Moori Bakhtiari N, Seify Abad Shapouri M, Salabi F, Khosravi M Iran J Vet Res. 2022; 23(3):229-236.

PMID: 36425606 PMC: 9681981. DOI: 10.22099/IJVR.2022.42349.6162.

subsp. CECT 7210 Reduces Inflammatory Cytokine Secretion in Caco-2 Cells Cultured in the Presence of CECT 515.

Alvarez-Mercado A, Plaza-Diaz J, de Almagro M, Gil A, Moreno-Munoz J, Fontana L Int J Mol Sci. 2022; 23(18).

PMID: 36142723 PMC: 9503999. DOI: 10.3390/ijms231810813.

References

Paredes-Sabja D, Torres J, Setlow P, Sarker M . Clostridium perfringens spore germination: characterization of germinants and their receptors. J Bacteriol. 2007; 190(4):1190-201. PMC: 2238220. DOI: 10.1128/JB.01748-07. View

Grootaert C, Boon N, Zeka F, Vanhoecke B, Bracke M, Verstraete W . Adherence and viability of intestinal bacteria to differentiated Caco-2 cells quantified by flow cytometry. J Microbiol Methods. 2011; 86(1):33-41. DOI: 10.1016/j.mimet.2011.03.011. View

McDonel J, McClane B . Production, purification, and assay of Clostridium perfringens enterotoxin. Methods Enzymol. 1988; 165:94-103. DOI: 10.1016/s0076-6879(88)65018-x. View

Parisot J, Carey S, Breukink E, Chan W, Narbad A, Bonev B . Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic. Antimicrob Agents Chemother. 2007; 52(2):612-8. PMC: 2224776. DOI: 10.1128/AAC.00836-07. View

Rowan N, Deans K, Anderson J, Gemmell C, Hunter I, Chaithong T . Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol. 2001; 67(9):3873-81. PMC: 93104. DOI: 10.1128/AEM.67.9.3873-3881.2001. View

Hong H, Huang J, Khaneja R, Hiep L, Urdaci M, Cutting S . The safety of Bacillus subtilis and Bacillus indicus as food probiotics. J Appl Microbiol. 2008; 105(2):510-20. DOI: 10.1111/j.1365-2672.2008.03773.x. View

Dunne C, OMahony L, Murphy L, Thornton G, Morrissey D, OHalloran S . In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001; 73(2 Suppl):386S-392S. DOI: 10.1093/ajcn/73.2.386s. View

Shelburne C, An F, Dholpe V, Ramamoorthy A, Lopatin D, Lantz M . The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother. 2007; 59(2):297-300. DOI: 10.1093/jac/dkl495. View

Teo A, Tan H . Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens. Appl Environ Microbiol. 2005; 71(8):4185-90. PMC: 1183296. DOI: 10.1128/AEM.71.8.4185-4190.2005. View

10.

Casey J, OCleirigh C, Walsh P, OShea D . Development of a robust microtiter plate-based assay method for assessment of bioactivity. J Microbiol Methods. 2004; 58(3):327-34. DOI: 10.1016/j.mimet.2004.04.017. View

11.

Sorokulova I, Pinchuk I, Denayrolles M, Osipova I, Huang J, Cutting S . The safety of two Bacillus probiotic strains for human use. Dig Dis Sci. 2007; 53(4):954-63. DOI: 10.1007/s10620-007-9959-1. View

12.

Wang X, Xia Y, Liu L, Liu M, Gu N, Guang H . Comparison of MTT assay, flow cytometry, and RT-PCR in the evaluation of cytotoxicity of five prosthodontic materials. J Biomed Mater Res B Appl Biomater. 2010; 95(2):357-64. DOI: 10.1002/jbm.b.31723. View

13.

La Ragione R, Casula G, Cutting S, Woodward M . Bacillus subtilis spores competitively exclude Escherichia coli O78:K80 in poultry. Vet Microbiol. 2001; 79(2):133-42. DOI: 10.1016/s0378-1135(00)00350-3. View

14.

Abriouel H, Maqueda M, Galvez A, Martinez-Bueno M, Valdivia E . Inhibition of bacterial growth, enterotoxin production, and spore outgrowth in strains of Bacillus cereus by bacteriocin AS-48. Appl Environ Microbiol. 2002; 68(3):1473-7. PMC: 123727. DOI: 10.1128/AEM.68.3.1473-1477.2002. View

15.

Chakrabarti G, Zhou X, McClane B . Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect Immun. 2003; 71(8):4260-70. PMC: 166005. DOI: 10.1128/IAI.71.8.4260-4270.2003. View

16.

Chakrabarti G, McClane B . The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol. 2004; 7(1):129-46. DOI: 10.1111/j.1462-5822.2004.00442.x. View

17.

Thirabunyanon M, Boonprasom P, Niamsup P . Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett. 2009; 31(4):571-6. DOI: 10.1007/s10529-008-9902-3. View

18.

McClane B, Chakrabarti G . New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin. Anaerobe. 2006; 10(2):107-14. DOI: 10.1016/j.anaerobe.2003.11.004. View

19.

Sanders M . Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008; 46 Suppl 2:S58-61. DOI: 10.1086/523341. View

20.

Fioramonti J, Theodorou V, Bueno L . Probiotics: what are they? What are their effects on gut physiology?. Best Pract Res Clin Gastroenterol. 2003; 17(5):711-24. DOI: 10.1016/s1521-6918(03)00075-1. View